Accessibility

Number of adults and children living with HIV who are currently receiving antiretroviral therapy in accordance with the nationally approved treatment protocol (or WHO/UNAIDS standards) at the end of the reporting period.

• Gender (female, male, other*)

• Age (0-14, 0–4, 5–9, 10–14, 10–19, 15+,15–24,15–49, 50+ years)

• Key populations (men who have sex with men, people living in prisons, people who inject drugs, sex workers, trans and gender diverse people)

• Cities and other administrative regions of epidemiologic importance

*The category of other includes trans and gender diverse people who choose an identity other than male or female.

The number of adults and children with HIV infection who are currently receiving antiretroviral combination therapy can be obtained through data collected from facility-based antiretroviral therapy registers or drug supply management systems. These are then tallied and transferred to cross-sectional monthly or quarterly reports which can then be aggregated for national totals. Patients receiving antiretroviral therapy in the private sector and public sector should be included in the numerator where data are available. Antiretroviral therapy taken only for the purpose of prevention of mother-to-child transmission and post-exposure prophylaxis are not included in this indicator. HIV-infected pregnant women who are eligible for antiretroviral therapy and on antiretroviral therapy for their own treatment are included in this indicator.

WHO, UNAIDS and UNICEF are responsible for reporting data for this indicator at the international level and have been compiling country specific data since 2003.

The data on people receiving antiretroviral therapy are collected through a joint international monitoring and reporting process with WHO, UNICEF and the UNAIDS Secretariat. For this purpose, a joint data tool has been developed that contains Global AIDS monitoring (GAM) indicators. Data are also compiled from the most recent reports received by WHO and/or UNAIDS from health ministries or from other reliable sources in the countries, such as bilateral partners, foundations and nongovernmental organizations that are major providers of treatment services. In order to facilitate collaboration at country level, the country offices of WHO, UNICEF and the UNAIDS Secretariat, work jointly with national counterparts and partner agencies to collate and validate data in a single collaborative consultation process. In addition, at least once a year, international data reconciliation meetings are organized to review and validate data reported to WHO, UNICEF, the UNAIDS Secretariat, the Global Fund to Fight AIDS, Tuberculosis and Malaria; and the United States President’s Emergency Plan for AIDS Relief. Where discrepancies are identified between data reported to the different organizations, follow-up letters are sent to UNAIDS, UNICEF and WHO country offices to liaise with national authorities to seek clarification and resolve discrepancies.

Regional estimates are calculated as the sum of country level data in each of the WHO regions.

Number

Annual

Annual

beusenbergm@who.int

Michel Beusenberg

2924